The generative AI in healthcare market, valued at USD 3.3 billion in 2025, is projected to reach USD 4.7 billion in 2026 and USD 39.8 billion by 2035, with a 26.7% CAGR during the forecast period 2026 to 2035. Implementing generative AI in pharma for administrative tasks can lead to substantial annual savings (of around $150 billion) across the healthcare sector. Furthermore, a study shows that it can reduce diagnostic errors by around 85% and reduce nursing overtime by 21%, translating into the...

Several industrial players are currently focusing on the development of advanced PCSK9 inhibitors and exploring more therapeutic potential. For instance, in June 2025, Merck (US) announced positive results of enlicitide decanoate, an investigation oral PCSK9 from the first two of three phase III clinical trials evaluating safety and efficacy. This drug is being evaluated under clinical trial for the treatment of adults with hyperlipidemia on lipid-lowering therapies. These positive outcomes and...

Currently, the global market for glycobiology is valued at USD 1.95 billion in 2025 and is poised to reach USD 6.77 billion by 2035, representing a CAGR of 13.2% during the forecast period. This lucrative growth is likely to be the result of increasing research on glycomics.To leverage the competitive edge, several industrial players are driving innovations, investments and partnerships in this field. For instance, in December 2024, GlycoNet (global leader in glycomics research and innovations)...

Printed circuit board market size is forecasted to reach USD 122.8 billion by 2035, growing at a 5.18% CAGR from USD 77.93 billion in 2026. Traditionally, PCB is composed of multiple layers including conductive and insulating layers that allow compact and organized placement of components. These boards are available in various types from single-sided, to multilayer boards which are widely used across different applications such as consumer electronics like smartphones, computers, medical devic...

The patient engagement solutions market, valued at USD 18.0 billion in 2025, is projected to reach USD 21.6 billion in 2026 and USD 96.7 billion by 2035, with a 18.1% CAGR during the forecast period 2026 to 2035. The current patient engagement solution providers landscape features around 420 large, mid-sized and small companies. It is worth mentioning that 98% of the solution providers offer solutions for home health management and more than 75% of the solution providers offer cloud-based deploy...

The global long acting drugs market, valued at USD 1.29 billion in 2025, is projected to reach USD 1.55 billion in 2026 and USD 4.62 billion by 2035, with a 12.9% CAGR during the forecast period 2026 to 2035. Many stakeholders have been making consolidated efforts to forge alliance with other industry / non-industry players for technology licensing, product development and manufacturing purposes. It is worth highlighting that over 90 strategic partnerships have been inked since 2018 in this mark...

The content delivery network market size is projected to grow from USD 24.25 billion in 2025 to USD 103.4 billion by 2035, representing a CAGR of 15.61% during the forecast period till 2035. The continuous evolution in content consumption has generated the need for powerful solutions to enhance network performance and boost content delivery. Also, the increasing prevalence of over-the-top (OTT) continues to raise the market demand for high-speed networks and faster content delivery. Besides this...

With growing concern of genetic disorders and chronic conditions across the globe, the healthcare industry has necessitated the carrier screening of prenatal and newborn. Several government organizations and industrial players are focusing on strategic initiatives to enhance carrier screening of individuals to determine couples at greater risk of genetic conditions. For instance, KK Women’s and Children’s Hospital and Temasek Foundation conjointly launched Temasek Foundation PREDICT (Parenth...

The global lyophilization services market, valued at USD 3.0 billion in 2025, is projected to reach USD 3.2 billion in 2026 and USD 4.7 billion by 2035, with a 4.3% CAGR during the forecast period 2026 to 2035. Antibodies market segment holds the largest share of the market and are poised to capture 52% of the overall revenue share by 2035.

The real-time location system market size is projected to grow from USD 8.17 billion in 2025 to USD 73.40 billion by 2035, representing a CAGR of 24.54% during the forecast period 2025-2035.

Recent research published by researchers at Mount Sinai in January 2025, led by Josep M. Llovet, MD, PhD, Professor of Medicine (Liver Diseases) at the Icahn School of Medicine at Mount Sinai have made a breakthrough in the treatment of hepatocellular carcinoma with combination approach. Under Phase III clinical study, “LEAP-012: Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma,” has show...

The global pen injectors market size, valued at USD 43.85 billion in 2024, is projected to reach USD 47.22 billion in 2025 and USD 87.19 billion by 2035, representing a CAGR of 6.3% during the forecast period. North America holds the largest share (41%), notably, Asia-Pacific is expected to see the highest growth due to increasing chronic illness rates and expanding healthcare access.

The biopreservation market for media, valued at USD 1.9 billion in 2025, is projected to reach USD 2.3 billion in 2026 and USD 15.5 billion by 2035, with a 23.6% CAGR during the forecast period 2026 to 2035. At present, over 60 players claim to offer more than 190 biopreservation and biobanking, intended for storage and preservation of different types of biological samples. Further, as per a study conducted by the USFDA, across more than 80% submissions for mesenchymal cell-based therapies, it w...

The global targeted drug delivery device market size is projected to grow from $427 Million in 2026 to $2,153 Million by 2035, representing a CAGR of 19.7% during the forecast period. The new research study consists of industry trends, detailed market analysis, clinical trial analysis, likely drug candidates and market impact analysis, along with the market forecast and opportunity analysis. Currently, there are more than 1,000 cell and gene therapies under development, most of which are being d...

The global biohacking market, valued at USD 23.63 billion in 2024, is projected to reach USD 28.73 billion in 2025 and USD 137.37 billion by 2035, representing a CAGR of 16.9% during the forecast period. As more market players continue to accelerate innovation in this field, we believe the global biohacking industry will continue to expand at a steady rate during the forecast period.

The global women health app market, valued at USD 3.45 billion in 2024, is projected to reach USD 5.29 billion in 2025 and USD 27.00 billion by 2035, representing a CAGR of 17.7% during the forecast period. Presently menstrual health holds the highest share (34%) of the market. Smartphone segment holds 59% of the overall revenue share. North America contributed 39% of the revenue share. Based on the type of age group, the global market for women health app is distributed into 15 to 24 years, 25...

The global biosimulation market size, valued at USD 3.45 billion in 2024, is projected to reach USD 4.18 billion in 2025 and USD 19.69 billion by 2035, representing a CAGR of 16.8% during the forecast period. According to our market report, presently the software segment occupies the highest biosimulation market share (62%), and the trend is likely to remain unchanged during the forecast period.

The global non-invasive aesthetic treatment market is estimated to grow from USD 26.24 billion in 2024 to reach USD 30.22 billion in 2025 and USD 86.08 billion by 2035, representing a CAGR of 11.0% during the forecast period. Non-invasive aesthetic treatment industry is experiencing remarkable growth and stands to continue the expansion in upcoming years.

The smart implants market is estimated to grow from USD 5.23 billion in 2024 to reach USD 6.36 billion in 2025 and USD 30.34 billion by 2035, representing a higher CAGR of 16.9% during the forecast period. Notably, industrial players, such as Abbott, Medtronic, OrthoSensor, and VeraSense are at the forefront of technological innovations in this field.

The global AI in mental health market, valued at USD 1.23 billion in 2024, is projected to reach USD 1.81 billion in 2025 and USD 27.77 billion by 2035, representing a CAGR of 31.4% during the forecast period. Owing to the increasing adoption of AI technologies in mental health, several market players have shown active interest in this field to develop advanced artificial intelligence-based solutions for patients with mental health conditions.